Economic Implications of Attention-Deficit Hyperactivity Disorder for Healthcare Systems

PharmacoEconomics

Volumn 21, Issue 17, 2003, Pages 1239-1262

  Leibson, Cynthia L ^a   Long, Kirsten Hall ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; METHYLPHENIDATE; PEMOLINE;

ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; COMORBIDITY; COST BENEFIT ANALYSIS; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HUMAN; JUVENILE; MENTAL HEALTH SERVICE; META ANALYSIS; PRIORITY JOURNAL; REVIEW; SIDE EFFECT;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CLINICAL TRIALS; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS;

EID: 0347589390     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200321170-00002     Document Type: Review

References (96)

1. Wolraich ML. Attention deficit hyperactivity disorder: the most studied and yet most controversial diagnosis. Ment Retard Dev Disabil Res Rev 1999; 5: 163-8
2. Barbaresi W, Katusic SK, Colligan RC, et al. How common is attention-deficit/hyperactivity disorder?: incidence in a population-based birth cohort in Rochester, Minn. Arch Pediatr Adolesc Med 2002; 156: 217-24
3. Sawyer MG, Arney FM, Baghurst PA, et al. The mental health of young people in Australia: key findings from the child and adolescent component of the national survey of mental health and well-being. Aust N Z J Psychiatry 2001; 35: 806-14
4. Angold A, Erkanli A, Egger HL, et al. Stimulant treatment for children: a community perspective. J Am Acad Child Adolesc Psychiatry 2000; 39: 975-84
5. Jensen PS, Kettle L, Roper MT, et al. Are stimulants over-prescribed?: treatment of ADHD in four US communities. J Am Acad Child Adolesc Psychiatry 1999; 38: 797-804
6. Pineda D, Ardila A, Rosselli M, et al. Prevalence of attention-deficit/ hyperactivity disorder symptoms in 4- to 17-year-old children in the general population. J Abnorm Child Psychol 1999; 27: 455-62
7. Rowland AS, Umbach DM, Catoe KE, et al. Studying the epidemiology of attention-deficit hyperactivity disorder: screening method and pilot results. Can J Psychiatry 2001; 46: 931-40
8. Wolraich ML, Hannah JN, Pinnock TY, et al. Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry 1996; 35: 319-24
9. Baumgaertel A, Wolraich ML, Dietrich M. Comparison of diagnostic criteria for attention deficit disorders in a German elementary school sample. J Am Acad Child Adolesc Psychiatry 1995; 34: 629-38
10. Abikoff HB, Jensen PS, Arnold LLE, et al. Observed classroom behavior of children with ADHD: relationship to gender and comorbidity. J Abnorm Child Psychol 2002; 30: 349-59
11. Rohde LA, Biederman J, Busnello EA, et al. ADHD in a school sample of Brazilian adolescents: a study of prevalence, comorbid conditions, and impairments. J Am Acad Child Adolesc Psychiatry 1999; 38: 716-22
12. Brock SW, Knapp PK. Reading comprehension abilities of children with attention-deficit/hyperactivity disorder. J Atten Disord 1996; 1: 173-86
13. Casey JE, Rourke BP, Del Dotto JE. Learning disabilities in children with attention deficit disorder with and without hyperactivity. Neuropsychol Dev Cogn Sect C Child Neuropsychol 1996; 2: 83-98
14. Barkley RA, Anastopoulos AD, Guevremont DC, et al. Adolescents with ADHD: patterns of behavioral adjustment, academic functioning, and treatment utilization. J Am Acad Child Adolesc Psychiatry 1991, 61
15. Szatmari P, Offord DR, Boyle MH. Correlates, associated impairments and patterns of service utilization of children with attention deficit disorder: findings from the Ontario Child Health Study. J Child Psychol Psychiatry 1989; 30: 205-17
16. Pope AW, Bierman KL, Mumma GH. Relations between hyperactive and aggressive behavior and peer relations at three elementary grade levels. J Abnorm Child Psychol 1989; 17: 253-67
17. Cantwell DP, Satterfield JH. The prevalence of academic under-achievement in hyperactive children. J Pediatr Psychol 1978; 3: 168-71
18. Fischer M, Barkley RA, Smallish L, et al. Young adult follow-up of hyperactive children: self-reported psychiatric disorders, comorbidity, and the role of childhood conduct problems and teen CD. J Abnorm Child Psychol 2002; 30: 463-75
19. Bagwell CL, Molina BS, Pelham Jr WE, et al. Attention-deficit hyperactivity disorder and problems in peer relations: predictions from childhood to adolescence. J Am Acad Child Adolesc Psychiatry 2001; 40: 1285-92
20. Rasmussen P, Gillberg C. Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study. J Am Acad Child Adolesc Psychiatry 2000, 31
21. Hansen C, Weiss D, Last CG. ADHD boys in young adulthood: psychosocial adjustment. J Am Acad Child Adolesc Psychiatry 1999; 38: 165-71
22. Mannuzza S, Klein RG, Bessler A, et al. Adult psychiatric status of hyperactive boys grown up. Am J Psychiatry 1998; 155: 493-8
23. Mannuzza S, Klein RG, Bessler A, et al. Adult outcome of hyperactive boys: educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 1993; 50: 565-76
24. Barkley RA, Fischer M, Edelbrock CS, et al. The adolescent outcome of hyperactive children diagnosed by research criteria: I. an 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1990; 29: 546-57
25. Fischer M, Barkley R, Fletcher K, et al. The adolescent outcome of hyperactive children diagnosed by research criteria. II: academic, attentional and neuropsychological status. J Consult Clin Psychol 1990; 58: 580-8
26. Greenfield B, Hechtman L, Weiss G. Two subgroups of hyperactives as adults: correlations of outcome. Can J Psychiatry 1988; 33: 505-8
27. Guevara J, Lozano P, Wickizer T, et al. Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder. Pediatrics 2001; 108: 71-8
28. Voigt RG, Barbaresi WJ, Colligan RC, et al. Occurrence of attention-deficit hyperactivity disorder (ADHD) among individuals with and without mild mental retardation in a population-based birth cohort [abstract]. J Dev Behav Pediatr 2001; 22: 349
29. Kadesjo B, Gillberg C. The comorbidity of ADHD in the general population of Swedish school-age children. J Child Psychol Psychiatry 2001; 42: 487-92
30. Bird HR, Gould MS, Staghezza BM. Patterns of diagnostic comorbidity in a community sample of children aged 9 through 16 years. J Am Acad Child Adolesc Psychiatry 1993; 32: 361-8
31. Leibson CL, Katusic SK, Barbaresi WJ, et al. Use and costs of medical care for children and adolescents with and without attention-deficit/ hyperactivity disorder. JAMA 2001; 285: 60-6
32. Woodward LJ, Fergusson DM, Horwood LJ. Driving outcomes of young people with attentional difficulties in adolescence. J Am Acad Child Adolesc Psychiatry 2000; 39: 627-34
33. DiScala C, Lescohier I, Barthel M, et al. Injuries to children with attention deficit hyperactivity disorder. Pediatrics 1998; 102: 1415-21
34. Barkley RA, Murphy KR, Kwasnik D. Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. Pediatrics 1996; 98: 1089-95
35. Lalloo R, Sheiham A. Risk factors for childhood major and minor head and other injuries in a nationally representative sample. Injury 2003; 34: 261-6
36. Sassi F, Archard L, McDaid D. Searching literature databases for health care economic evaluations: how systematic can we afford to be? Med Care 2002; 40: 387-94
37. Kelleher KJ, McInerny TK, Gardner WP, et al. Increasing identification of psychosocial problems: 1979-1996. Pediatrics 2000; 105: 1313-21
38. Hoagwood K, Kelleher KJ, Feil M, et al. Treatment services for children with ADHD: a national perspective. J Am Acad Child Adolesc Psychiatry 2000; 39: 198-206
39. Rushton J, Bruckman D, Kelleher K. Primary care referral of children with psychosocial problems. Arch Pediatr Adolesc Med 2002; 156: 592-8
40. Robison LM, Skaer TL, Sclar DA, et al. Is attention deficit hyperactivity disorder increasing among girls in the US?: trends in the diagnosis and the prescribing of stimulants. CNS Drugs 2002; 16: 129-37
41. Zito JM, Safer DJ, dosReis S, et al. Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder. Arch Pediatr Med 1999; 153: 1257-63
42. Pastor PN, Reuben C. Attention deficit hyperactivity disorder and learning disability: United States, 1997-98. National Center for Health Statistics Vital and Health Statistics 2002 Series 206, Number 206. Poster presented at the Academy for Health Services Research and Health Policy Annual Research Meeting; 2002 Jun 23-25; Washington, D.C
43. Bussing R, Zima BT, Perwien AR, et al. Children in special education programs: attention deficit hyperactivity disorder, use of services, and unmet needs. Am J Public Health 1998; 88: 880-6
44. Miller AR, Lalonde CE, McGrail KM, et al. Prescription of methylphenidate to children and youth: 1990-1996. CMAJ 2001; 165: 1505-6
45. Brownell MD, Yogendran MS. Attention-deficit hyperactivity disorder in Manitoba children: medical diagnosis and psychostimulant treatment rates. Can J Psychiatry 2001; 46: 264-72
46. Fogelman Y, Kahan E. Methylphenidate use for attention deficit hyperactivity disorder in northern Israel: a controversial issue. Isr Med Assoc J 2001; 3: 925-7
47. Schirm E, Tobi H, Zito JM, et al. Psychotropic medication in children: a study from the Netherlands [abstract]. Pediatrics 2001; 108: E25
48. Reid R, Hakendof P, Prosser B. Use of psychostimulant medication for ADHD in South Australia. J Am Acad Child Adolesc Psychiatry 2002; 41: 906-13
49. Safer DJ, Malever M. Stimulant treatment in Maryland public schools. Pediatrics 2000; 106: 533-9
50. Rowland AS, Umbach DM, Stallone L, et al. Prevalence of medication treatment for attention deficit-hyperactivity disorder among elementary school children in Johnston County, North Carolina. Am J Public Health 2002; 92: 231-4
51. Rushton JL, Whitmire JT. Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends 1992 to 1998. Arch Pediatr Adolesc Med 2001; 155: 560-5
52. Leslie DL, Rosenheck RA, Horwitz SM. Patterns of mental health utilization and costs among children in a privately insured population. Health Serv Res 2001; 36: 113-27
53. Chan E, Zhan C, Homer CJ. Health care use and costs for children with attention-deficit/hyperactivity disorder: national estimates from the Medical Expenditure Panel Survey. Arch Pediatr Adolesc Med 2002; 156: 504-11
54. Kelleher KJ, Childs GE, Harman JS. Healthcare costs for children with attention-deficit hyperactivity disorder. Econ Neurosci 2001; 3: 60-3
55. National Institutes of Health CDC. Diagnosis and treatment of attention deficit hyperactivity disorder. NIH Consensus Statement, 1998 [online] Available from URL: http://odp.od.nih.gov/consensus/cons/110/110_statement.htm. [Accessed 2002 Nov]
56. American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children, adolescents, and adults with ADHD. J Am Acad Child Adolesc Psychiatry 1997; 36: 85S-121S
57. Zwillich T. Mental health benefits slashed over past decade. Clin Psychiatry News 1998; 26: 1-2
58. Zwillich T. Mental health benefits continue 10-year decline. Clin Psychiatry News 1999; 27: 31
59. Agency for Health Care Research and Quality. What is MEPS? [online]. Available from URL: http://www.meps.ahrq.gov/WhatIsMEPS/Overview.HTM [Accessed 2002 Nov]
60. Katusic SK, Colligan RC, Barbaresi WJ, et al. Potential influence of migration bias in birth cohort studies. Mayo Clin Proc 1998; 73: 1053-61
61. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994
62. Melton III LJ. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996; 71: 266-74
63. Miller A, Lee SK, Raina P. Part 1: overview and clinical evaluation of the use of methylphenidate for attention-deficit/hyperactivity disorder. In: Miller A, Lee SK, Raina P, et al., editors. A review of therapies for attention-deficit/hyperactivity disorder. Ottawa, Canada: Canadian Coordinating Office for Health Technology Assessment (CCOHTA), 1998
64. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd rev. ed. Washington, DC: American Psychiatric Association, 1987
65. Shaffer D, Schwab-Stone M, Fisher P, et al. The diagnostic interview schedule for children-revised versions (DISC-R): preparation, field testing, interrater reliability, and acceptability. J Am Acad Child Adolesc Psychiatry 1993; 32: 643-50
66. Greenhill LL, Findling RL, Swanson JM, et al. A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder [abstract]. Pediatrics 2002; 109: E39
67. Jensen PS, Hinshaw SP, Swanson JM, et al. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr 2001; 22: 60-73
68. James RS, Sharp WS, Bastain TM, et al. Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD. J Am Acad Child Adolesc Psychiatry 2001; 40: 1268-76
69. Marchetti A, Magar R, Lau H, et al. Pharmacotherapies for attention-deficit/hyperactivity disorder: expected-cost analysis. Clin Ther 2001; 23: 1904-21
70. Schachter HM, Pham BA, King J, et al. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? CMAJ 2001; 165: 1475-88
71. Jadad AR, Boyle M, Cunningham C, et al. Treatment of Attention deficit/ hyperactivity disorder: evidence report/technology assessment (summary). Rockville (MD): Agency for Healthcare Research and Quality, 1999: 1-341
72. Klassen A, Miller A, Raina P, et al. Attention-deficit hyperactivity disorder in children and youth: a quantitative systematic review of the efficacy of different management strategies. Can J Psychiatry 1999; 44: 1007-16
73. Gillberg C, Melander H, von Knorring AL, et al. Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 1997; 54: 857-64
74. Efron D, Jarman F, Barker M. Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics 1997; 100: 662-6
75. Gilmore A, Milne R. Methylphenidate in children with hyperactivity: review and cost-utility analysis. Pharmacoepidemiol Drug Saf 2001; 10: 85-94
76. Zupancic JAF, Miller A, Raina P, et al. Part 3: economic evaluation of pharmaceutical and psychological/ behavioral therapies for attention-deficit/ hyperactivity disorder. In: Miller A, Lee SK, Raina P, et al., editors. A review of therapies for attention-deficit/hyperactivity disorder [online]. Ottawa, Canada: Canadian Coordinating Office for Health Technology Assessment (CCOHTA), 1998. Available from URL: http://www.ccohta.ca/publications/pdf/ adhd_tech_rep.pdf [Accessed 2003 Oct 16]
77. Rosser R, Cottee M, Rabin R, et al. Index of health related quality of life. In: Hopkins A, editor. Measures of the quality of life, and the uses to which they may be put. London: Royal College of Physicians of London, 1992: 81-89
78. Shukla VK, Otten N. Assessment of attention deficit/hyperactivity disorder therapy: a Canadian perspective [online]. Available at URL: http://www.ccohta.ca/publications/pdf/overadhdeng.pdf [Accessed: 2002 Nov]
79. Conners CK. Manual for Conners' rating scales. Toronto, Canada: Multi-Health Systems Inc, 1989
80. Hoagwood K, Jensen PS, Feil M, et al. Medication management of stimulants in pediatric practice settings: a national perspective. J Dev Behav Pediatr 2000; 21: 322-31
81. Rushton JL, Felt BT, Roberts MW. Coding of pediatric behavioral and mental disorders [online]. Available from URL: http://wwwpediatrics.org/cgi/ content/full/110/1/e8. [Accessed 2002 Nov]
82. Mannuzza S, Klein RG, Bessler A, et al. Educational and occupational outcome of hyperactive boys grown up. J Am Acad Child Adolesc Psychiatry 1997; 36: 1222-7
83. Weiss G, Hechtman L, Milroy T, et al. Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Psychiatry 1985; 24: 211-20
84. Hechtman L, Weiss G, Perlman T. Young adult outcome of hyperactive children who received long-term stimulant treatment. J Am Acad Child Psychiatry 1984; 23: 261-9
85. Lambert NM, Hartsough CS. Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. J Learn Disabil 1998; 31: 533-44
86. Fergusson DM, Lynskey MT, Horwood LJ. Attentional difficulties in middle childhood and psychosocial outcomes in young adulthood. J Child Psychol Psychiatry 1997; 38: 633-44
87. Schaughency E, McGee R, Raja SN, et al. Self-reported inattention, impulsivity, and hyperactivity at ages 15 and 18 years in the general population. J Am Acad Child Adolesc Psychiatry 1994; 33: 173-84
88. Wilens TE, Faraone SV, Biederman J, et al. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse?: a meta-analytic review of the literature. Pediatrics 2003; 111: 179-85
89. Biederman J, Wilens T, Mick E, et al. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder [abstract]. Pediatrics 1999; 104: e20
90. Earle CC, Tsai JS, Gelber RD, et al. Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis. J Clin Oncol 2001; 19: 1064-70
91. McClellan MB, Newhouse JP. Instrumental variables analysis applications in health services research: a special supplement to HSR. Health Serv Res 2000; 35: 1061-202
92. Joffe MM, Rosenbaum PR. Invited commentary: propensity scores. Am J Epidemiol 1999; 150: 327-33
93. Rosenbaum PR, Rubin DB. Reducing bias in observational studies using a subclassification on the propensity score. J Am Stat Assoc 1984; 79: 516-24
94. Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ 2001; 20: 461-94
95. Blough DK, Ramsey SD. Using generalized linear models to assess medical care coats. Health Serv Outcomes Res Methodol 2000; 1: 185-202
96. Mrazek DA. A crisis in child psychiatric service delivery: why hasn't the piper been paid? Mayo Clin Proc 2001; 76: 1078-80